Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2.

Source:http://linkedlifedata.com/resource/pubmed/id/12016262

Circ. Res. 2002 May 17 90 9 966-73

Download in:

View as

Triples

General Info

PMID
12016262